Post by
Impalaman on Aug 23, 2021 8:24am
PHIZER just bought Trillium ---for--
about 3. billion CAD----now it's our turn.
Comment by
Oilminerdeluxe on Aug 23, 2021 9:06am
I have a hard time seeing someone buying a 43 M market cap stock for 3 B, but I will niot complain if it happens. Right now, I yearn for signs of life. That newsletter better have some good stuff in it and not be a cut and paste thing.
Comment by
99942Apophis on Aug 23, 2021 4:33pm
Quite correct gojotv, if this was a one trick pony sure 3B buyout would be adequate. When we're looking at Bladder, lung, brain and an all virus & pathogen destroyer then yes you are in the ballpark at 100 bucks a share! We just need irrefutable proof from this trial that it does what we believe.
Comment by
Pandora on Aug 23, 2021 10:35pm
And what does a 200% premium to 20.5 cents give us??
Comment by
enriquesuave on Aug 23, 2021 11:52pm
Trillium partnered with Pfizer last September (2 PH1 drugs) and almost a year later they get bought out. The way it seems to go 1) Good data. 2) partnership with big Pharma which leads up to 3) Buy Out. Just IMHO
Comment by
HomerAndCompany on Aug 24, 2021 7:30am
My math says a 200% premium on 20.5 cents is the low 60 cent range. But maybe we could see a 200% premium on a future higher SP? A $5 SP for example would give TLT a market cap of just over $1 billion, and a 200% premium on that would be just over $3 billion & $15/share.
Comment by
enriquesuave on Aug 24, 2021 7:36am
Trillium was trading at 35 cents in November 2019 and now is at $22 dollars Canadian. No worries for SP of TLT if we get the same outcome.
Comment by
gonefishing2022 on Aug 24, 2021 7:50am
I THINK YOU GUYS ARE A LITTLE IN DREAM WORLD BUT IT'S TERRIFIC WHEN THAT HAPPENS.
Comment by
HomerAndCompany on Aug 24, 2021 8:02am
Yes!. But it's a dream ($15, $20+/share) that could come true! Obviously not the only possible outcome or the current SP would not be $0.205.